Austria · Delayed Price · Currency is EUR Banca Mediolanum Statistics
Total Valuation
VIE:BMED has a market cap or net worth of EUR 14.72 billion.
| Market Cap | 14.72B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Nov 24, 2025 |
Share Statistics
| Current Share Class | 739.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.09% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | 6.90% |
| Owned by Institutions (%) | 9.81% |
| Float | 244.83M |
Valuation Ratios
The trailing PE ratio is 11.89 and the forward PE ratio is 14.56.
| PE Ratio | 11.89 |
| Forward PE | 14.56 |
| PS Ratio | 6.88 |
| PB Ratio | 3.32 |
| P/TBV Ratio | 3.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.27%.
| Return on Equity (ROE) | 29.27% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 541,026 |
| Profits Per Employee | 312,917 |
| Employee Count | 3,956 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VIE:BMED has paid 337.30 million in taxes.
| Income Tax | 337.30M |
| Effective Tax Rate | 21.41% |
Stock Price Statistics
The stock price has increased by +56.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +56.87% |
| 50-Day Moving Average | 19.18 |
| 200-Day Moving Average | 16.68 |
| Relative Strength Index (RSI) | 60.78 |
| Average Volume (20 Days) | 351 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VIE:BMED had revenue of EUR 2.14 billion and earned 1.24 billion in profits. Earnings per share was 1.67.
| Revenue | 2.14B |
| Gross Profit | 2.14B |
| Operating Income | 1.48B |
| Pretax Income | 1.58B |
| Net Income | 1.24B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.67 |
Balance Sheet
The company has 1.79 billion in cash and 4.31 billion in debt, with a net cash position of -2.52 billion.
| Cash & Cash Equivalents | 1.79B |
| Total Debt | 4.31B |
| Net Cash | -2.52B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.43B |
| Book Value Per Share | 6.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 69.32% |
| Pretax Margin | 73.60% |
| Profit Margin | 57.84% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.23, which amounts to a dividend yield of 6.02%.
| Dividend Per Share | 1.23 |
| Dividend Yield | 6.02% |
| Dividend Growth (YoY) | 55.70% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 1.09% |
| Shareholder Yield | 7.11% |
| Earnings Yield | 8.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |